Showing results (261-270 of 31,336) with videos related to
Sort By:
Pageof 3,134
Journal of Medicinal Chemistry|May 10, 2019
Design and Synthesis of TASIN Analogues Specifically Targeting Colorectal Cancer Cell Lines with Mutant Adenomatous Polyposis Coli (APC)Wentian Wang, Lu Zhang, Lorraine Morlock, et al.Journal of Medicinal Chemistry|April 10, 2019
Targeting the Thioredoxin System as a Strategy for Cancer TherapyMianli Bian, Rong Fan, Sai Zhao, et al.Journal of Medicinal Chemistry|April 10, 2019
Discovery and Characterization of XY101, a Potent, Selective, and Orally Bioavailable RORγ Inverse Agonist for Treatment of Castration-Resistant Prostate CancerYan Zhang, Xishan Wu, Xiaoqian Xue, et al.Journal of Medicinal Chemistry|October 1, 1987
Synthesis and antitumor activity of tropolone derivatives. 6. Structure-activity relationships of antitumor-active tropolone and 8-hydroxyquinoline derivativesM Yamato, K Hashigaki, Y Yasumoto, et al.Journal of Medicinal Chemistry|January 1, 1988
Synthesis and biological evaluation of 8-deazahomofolic acid and its tetrahydro derivativeJ I DeGraw, W T Colwell, V H Brown, et al.Journal of Medicinal Chemistry|October 28, 1997
Search for DNA repair inhibitors: selective binding of nucleic bases-acridine conjugates to a DNA duplex containing an abasic siteN Berthet, J F Constant, M Demeunynck, et al.Journal of Medicinal Chemistry|October 28, 1997
Synthesis of gonadotropin-releasing hormone III analogs. Structure-antitumor activity relationshipsI Mezö, S Lovas, I Pályi, et al.Journal of Medicinal Chemistry|October 28, 1997
Potent alpha 4 beta 1 peptide antagonists as potential anti-inflammatory agentsD Y Jackson, C Quan, D R Artis, et al.Journal of Medicinal Chemistry|October 28, 1997
Phenylimidazolidin-2-one derivatives as selective 5-HT3 receptor antagonists and refinement of the pharmacophore model for 5-HT3 receptor bindingF Heidempergher, A Pillan, V Pinciroli, et al.Journal of Medicinal Chemistry|October 28, 1997
Structure-activity relationships of (4-acylpyrrol-2-yl)alkanoic acids as inhibitors of the cytosolic phospholipase A2: variation of the substituents in positions 1, 3, and 5M LehrPageof 3,134